Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials

Ophthalmology

Volumn 123, Issue 4, 2016, Pages 865-875

  Sharma, Sumit ^a   Toth, Cynthia A ^a   Daniel, Ebenezer ^b   Grunwald, Juan E ^b   Maguire, Maureen G ^b   Ying, Gui Shuang ^b   Huang, Jiayan ^b   Martin, Daniel F ^c   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; BODY FLUID; EYE PHOTOGRAPHY; FOLLOW UP; FUNDUS PHOTOGRAPHY; GEOGRAPHIC ATROPHY; HUMAN; INTRARETINAL FLUID; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA HEMORRHAGE; RETINA TEAR; RETINAL SCAR; RETINAL THICKNESS; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SUBRETINAL PIGMENT EPITHELIUM FLUID; VISUAL ACUITY; AGED; ANTAGONISTS AND INHIBITORS; CHOROIDAL NEOVASCULARIZATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOGRAPHY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; RETINAL PIGMENT EPITHELIUM; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; COHORT STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; GEOGRAPHIC ATROPHY; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MALE; PHOTOGRAPHY; PROSPECTIVE STUDIES; RANIBIZUMAB; RETINAL PIGMENT EPITHELIUM; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84953431892     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.12.002     Document Type: Article

References (11)

1. G.J. Jaffe, D.F. Martin, C.A. Toth, and et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials Ophthalmology 120 2013 1860 1870
2. CATT Research Group D.F. Martin, M.G. Maguire, G.S. Ying, and et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
3. Comparison of Age-related Macular Degeneration Treatments Trials Research Group D.F. Martin, M.G. Maguire, S.L. Fine, and et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
4. F.C. DeCroos, C.A. Toth, S.S. Stinnett, and et al. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials Ophthalmology 119 2012 2549 2557
5. J.E. Grunwald, E. Daniel, G.S. Ying, and et al. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 2012 1634 1641
6. A. Chan, J.S. Duker, T.H. Ko, and et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography Arch Ophthalmol 124 2006 193 198
7. U. Schmidt-Erfurth, S.M. Waldstein, G.G. Deak, and et al. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration Ophthalmology 122 2015 822 832
8. K.V. Bhavsar, and K.B. Freund Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluid Saudi J Ophthalmol 28 2014 129 133
9. C. Gianniou, A. Dirani, L. Jang, and I. Mantel Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: functional and structural outcome Retina 35 2015 1195 1201
10. IVAN Study Investigators U. Chakravarthy, S.P. Harding, C.A. Rogers, and et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 2012 1399 1411
11. Stone TW, ed. ASRS 2014 Preferences and Trends Membership Survey: Chicago, IL. American Society of Retina Specialists; 2014